全文获取类型
收费全文 | 11130篇 |
免费 | 827篇 |
国内免费 | 37篇 |
专业分类
耳鼻咽喉 | 65篇 |
儿科学 | 332篇 |
妇产科学 | 315篇 |
基础医学 | 1910篇 |
口腔科学 | 139篇 |
临床医学 | 1118篇 |
内科学 | 2396篇 |
皮肤病学 | 177篇 |
神经病学 | 824篇 |
特种医学 | 328篇 |
外国民族医学 | 1篇 |
外科学 | 1578篇 |
综合类 | 86篇 |
一般理论 | 23篇 |
预防医学 | 806篇 |
眼科学 | 187篇 |
药学 | 688篇 |
中国医学 | 13篇 |
肿瘤学 | 1008篇 |
出版年
2023年 | 53篇 |
2022年 | 84篇 |
2021年 | 231篇 |
2020年 | 148篇 |
2019年 | 241篇 |
2018年 | 267篇 |
2017年 | 158篇 |
2016年 | 194篇 |
2015年 | 252篇 |
2014年 | 334篇 |
2013年 | 506篇 |
2012年 | 787篇 |
2011年 | 846篇 |
2010年 | 487篇 |
2009年 | 383篇 |
2008年 | 760篇 |
2007年 | 803篇 |
2006年 | 776篇 |
2005年 | 753篇 |
2004年 | 716篇 |
2003年 | 662篇 |
2002年 | 667篇 |
2001年 | 96篇 |
2000年 | 84篇 |
1999年 | 113篇 |
1998年 | 166篇 |
1997年 | 105篇 |
1996年 | 101篇 |
1995年 | 87篇 |
1994年 | 67篇 |
1993年 | 62篇 |
1992年 | 60篇 |
1991年 | 44篇 |
1990年 | 40篇 |
1989年 | 41篇 |
1988年 | 26篇 |
1987年 | 42篇 |
1986年 | 31篇 |
1985年 | 33篇 |
1984年 | 52篇 |
1983年 | 47篇 |
1982年 | 53篇 |
1981年 | 59篇 |
1980年 | 75篇 |
1979年 | 40篇 |
1978年 | 34篇 |
1976年 | 24篇 |
1975年 | 23篇 |
1974年 | 31篇 |
1973年 | 22篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
Gene transfer approaches using viruses such human adenovirus (HAdV) may provide an alternative treatment for diseases involving hematopoietic cells. Better understanding of the cellular mechanisms by which the HAdV introduces DNA into these cells should help in vector design. We examined HAdV intracellular delivery in several cell lines including B and T lymphocytes. We demonstrated that HAdV resistance in most B lymphocytes is the result of moderate HAdV uptake. In contrast, high levels of coxsackie and HAdV receptor (hCAR) are expressed on the surface of HSB2 (T cells), allowing efficient binding and uptake but no transgene expression, probably because of deficient endosomolysis and subsequent exocytose. This work demonstrates the existence of hCAR-dependent and -independent endocytic route in hematopoietic cells. Moreover, it precises the intracellular barriers to be overcome by HAdV in such cells to be infectious and gives previous information's to design new vectors for gene transfer. 相似文献
72.
Origin and filiation of human plasmacytoid dendritic cells 总被引:8,自引:0,他引:8
Brière F Bendriss-Vermare N Delale T Burg S Corbet C Rissoan MC Chaperot L Plumas J Jacob MC Trinchieri G Bates EE 《Human immunology》2002,63(12):1081-1093
Human plasmacytoid dendritic cells represent a rare population of leukocytes which produce high amounts of type I interferon in response to certain viruses. Although those cells were first described in 1958, there are still unsolved issues related to their origin and function. Recently, a leukemic counterpart of plasmacytoid dendritic cells was identified. Molecular approaches using either normal or leukemic plasmacytoid dendritic cells provide some new insights into the controversial lymphoid origin of those cells. The need for specific markers is still a critical aspect for the identification of plasmacytoid dendritic cells, whatever stage of differentiation, in normal as well as in pathological conditions. Hopefully, novel markers will allow delineation of the relationships between dendritic cells at different stages of differentiation/maturation along the myeloid and lymphoid lineages. 相似文献
73.
Ekouevi DK Rouet F Becquet R Inwoley A Viho I Tonwe-Gold B Bequet L Dabis F Leroy V;ANRS / Ditrame Plus Study Group 《Journal of acquired immune deficiency syndromes (1999)》2004,36(2):755-757
The aim of this study performed in Abidjan, C?te d'Ivoire, was to describe the distribution of CD4+ T-cell lymphocytes (CD4) in HIV-1-infected (HIV+) pregnant women diagnosed during prenatal voluntary counseling and testing and to assess whether HIV-related immunodeficiency influenced the acceptance of an antiretroviral (ARV) package (zidovudine beginning at 36 weeks of amenorrhea plus intrapartum nevirapine) to prevent mother-to-child transmission. Between April and June 2002, a CD4 count was systematically performed in all HIV+ women (n=221) in 5 antenatal clinics carrying out voluntary counseling and testing. No difference in CD4 count was found in HIV+ women who did not return for their test result (n=50) and those who were informed of their positive serostatus (n=171) (median CD4 count: 389/mm3 vs. 420/mm3; P=0.19). We also found a lack of difference in CD4 count in those who accepted ARV (n=72) and those who did not but knew their HIV status (n=99) (median CD4 count: 405/mm3 vs. 425/mm3; P=0.47). The overall uptake of the intervention (31.9%) appeared to be independent of the maternal immune status. 相似文献
74.
Geskus RB Meyer L Hubert JB Schuitemaker H Berkhout B Rouzioux C Theodorou ID Delfraissy JF Prins M Coutinho RA 《Journal of acquired immune deficiency syndromes (1999)》2005,39(3):321-326
OBJECTIVE: To investigate the causal pathways by which age and the CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles influence progression to AIDS. DESIGN: Analysis of follow-up data from 2 cohort studies among homosexual men (n=400), having >10 years of follow-up. METHODS: The effects of the 4 cofactors on the CD4 and HIV-1 RNA trajectories after seroconversion were modeled in a random-effects model. A proportional hazards model was used to investigate their effect on the risk of AIDS after correction for CD4 cell count and RNA level. This approach allows investigation as to whether they influence AIDS progression by affecting CD4 count and RNA level or by other pathways. RESULTS: Persons of younger age or having the CCR2-64I or SDF-1 3'A mutation have significantly higher CD4 levels. Persons with the CCR5-Delta32 deletion or CCR2-64I mutation have significantly lower RNA levels. After correction for both CD4 count and RNA level, only the SDF-1 3'A mutation significantly increases the AIDS risk. CONCLUSIONS: Age and the CCR5-Delta32 deletion and CCR2-64I mutation influence AIDS progression by affecting CD4 and HIV-1 RNA. The SDF-1 3'A allele increases the AIDS risk, but this effect is countered by its effect on CD4 and HIV-1 RNA level. 相似文献
75.
76.
Baujat G Rio M Rossignol S Sanlaville D Lyonnet S Le Merrer M Munnich A Gicquel C Colleaux L Cormier-Daire V 《American journal of medical genetics. Part C, Seminars in medical genetics》2005,(1):4-11
Here, we report the clinical and molecular analysis of 75 patients with overgrowth and mental retardation, including 45 previously reported cases [Rio et al., 2003; Baujat et al., 2004]. Two groups are distinguished: group I corresponding to patients with recognizable overgrowth syndromes (Sotos syndrome (SS), Weaver syndrome (WS), Beckwith-Wiedemann syndrome, Simpson-Golabi-Behmel syndrome (SGBS), and del(22)(qter) syndrome) (60 cases) and group II corresponding to unclassified cases (15 patients). We investigated NSD1 and GPC3 deletions or mutations, 11p15 abnormalities, and 22qter deletions. Surprisingly, in Group I, two SS patients had 11p15 abnormalities and two patients with Beckwith-Wiedemann syndrome had NSD1 aberrations. In group II, two cases of del(22)(qter) were identified but neither NSD1, 11p15, nor GPC3 abnormalities were detected. These results emphasize the clinical and molecular overlap in overgrowth conditions. 相似文献
77.
The recent demonstration that about 20–30% of cases of Down syndrome are of paternal origin has again raised interest in the question of the possible contribution of paternal age independent of maternal age to a couple's risk of a Down syndrome live birth. In this paper the nature of the available evidence is critically reviewed, interpretations reconciling differences between studies that reached opposite conclusions are presented, and an approach to genetic counseling in the face of such apparent differences in the literature is discussed. It is not likely that data from ad hoc studies of parental origin of the extra chromosome will be sufficient to judge the existence or magnitude of paternal age-specific risk, and reliance must be made on statistical studies that searched for paternal age effects while controlling for maternal age. The literature is consistent with an apparent doubling of risk for paternal age 55 and over, but no effect at younger paternal ages. With regard to remarriage, it is suggested that if members of a couple with a 47, +21 child remarry it be assumed that the excess risk “travels” to that new couple which includes the parent in whom non-disjunction occurred in the previous marriage. If parental origin is not known, it is suggested that the risk be calculated on the assumption of a 20–30% likelihood that it was of paternal origin and a 70–80% likelihood that it was of maternal origin, and that the excess empiric risks be apportioned accordingly in the new marriages. 相似文献
78.
Ray V. Haning Ian H. Carlson Enid F. Gilbert Sander S. Shapiro John M. Opitz Laurence E. Karp 《American journal of medical genetics. Part A》1980,7(3):279-292
The second case of virilism as a late manifestation of Bardet-Biedl syndrome (BBS) is described, with endocrine and histological evaluation. Both cases manifested ovulatory cycles and developed virilism in adulthood. Elevated plasma testosterone and 17-OH-progesterone were not suppressed by dexamethasone but were suppressed by medroxyprogesterone acetate. Peripheral and ovarian venous blood obtained at the time of surgery demonstrated a marked gradient for testosterone in both ovaries and for progesterone in the ovary bearing the corpus luteum. Histological evaluation of the ovaries demonstrated bilateral ovarian stromal hyperplasia with focal hyperthecosis. Bilateral ovariectomy resulted in complete correction of the endocrine abnormality, although the established hirsutism remains a mark of previous androgen excess. 相似文献
79.
80.